15-82659654-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001278512.2(AP3B2):c.3212G>A(p.Arg1071Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,613,786 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001278512.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AP3B2 | NM_001278512.2 | c.3212G>A | p.Arg1071Gln | missense_variant | 27/27 | ENST00000535359.6 | NP_001265441.1 | |
CPEB1-AS1 | NR_046096.1 | n.1328+9508C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AP3B2 | ENST00000535359.6 | c.3212G>A | p.Arg1071Gln | missense_variant | 27/27 | 1 | NM_001278512.2 | ENSP00000440984 | ||
CPEB1-AS1 | ENST00000560650.1 | n.1328+9508C>T | intron_variant, non_coding_transcript_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152132Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 249128Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135156
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461654Hom.: 0 Cov.: 31 AF XY: 0.0000124 AC XY: 9AN XY: 727118
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152132Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74322
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2022 | The c.3155G>A (p.R1052Q) alteration is located in exon 26 (coding exon 26) of the AP3B2 gene. This alteration results from a G to A substitution at nucleotide position 3155, causing the arginine (R) at amino acid position 1052 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 22, 2022 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1052 of the AP3B2 protein (p.Arg1052Gln). This variant is present in population databases (rs756112219, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with AP3B2-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glutamine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at